Active Ingredient History

NOW
  • Now
Sildenafil (Viagra, Revatio) is a PDE5 inhibitor which was approved by FDA for the treatment of erectile disfunction and adults with pulmonary arterial hypertension. Upon administration sildenafil inhibits PDE5 and results in elevated level of cyclic guanosine monophosphate and smooth muscle relaxation.   NCATS

  • SMILES: CCCc1nn(C)c2C(=O)NC(=Nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4
  • InChIKey: BNRNXUUZRGQAQC-UHFFFAOYSA-N
  • Mol. Mass: 474.59
  • ALogP: 1.61
  • ChEMBL Molecules:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Oral, Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$0.0600 - $75.4625

Australia

$2.1907 - $11.7303
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine | nipatra | revatio | sildenafil | sildenafil citrate | sildenefil | uk-92480 | uk-9248010 | uk-92480-10 | viagra | vizarsin

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue